Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
08/2008
08/20/2008EP1958613A1 Dermal film-forming liquid formulations for drug release to skin
08/20/2008EP1958522A2 Functional food having positive effects in the prevention of cardiovascular diseases
08/20/2008EP1958521A1 Method of improving absorbability of epigallocatechin, food, drink and food/drink material using the same and method of producing the same
08/20/2008EP1958503A2 Expression of secreted human alpha-fetoprotein in transgenic animals
08/20/2008EP1957986A2 Intraocular pressure-regulated early genes and uses thereof
08/20/2008EP1957676A2 Antineoplasics activities of ellipticine and its derivatives
08/20/2008EP1957647A2 Immunostimulatory oligoribonucleotides
08/20/2008EP1957646A1 Compositions and methods for therapy and diagnosis of cancer
08/20/2008EP1957516A2 Alfa-helix mimetics and method relating to the treatment of cancer stem cells
08/20/2008EP1957515A2 PRODRUG ERbeta-SELECTIVE SUBSTANCES, METHODS FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAID COMPOUNDS
08/20/2008EP1957514A1 Prodrugs of er-beta-selective substances method for production thereof and pharmaceutical compositions comprising the same
08/20/2008EP1957513A2 Sulfamoyl sulfonate prodrugs
08/20/2008EP1957512A1 17.beta.-fluoromethoxycarbonyl-androst-4-en-3-one compounds with a 17.alpha.-carbonate substituent
08/20/2008EP1957510A1 Antiviral nucleosides
08/20/2008EP1957509A2 Methods and compositions for the treatment of gastrointestinal disorders
08/20/2008EP1957508A2 Ketolide derivatives as antibacterial agents
08/20/2008EP1957507A2 Antibacterial 4,5-substituted aminoglycoside analogs having multiple substituents
08/20/2008EP1957499A1 4-anilino-substituted quinazoline derivatives as tyrosine kinase inhibitors
08/20/2008EP1957498A2 Inhibitors of vegf receptor and hgf receptor signaling
08/20/2008EP1957496A2 Bicyclic protein kinase inhibitors
08/20/2008EP1957495A1 Fused heterocyclic compound
08/20/2008EP1957494A2 Lactam compounds and methods of using the same
08/20/2008EP1957492A2 Substituted bicyclic pyrimidone derivatives
08/20/2008EP1957491A2 Pyrrolo (2,3-b) pyridine derivatives useful as tec kinase inhibitors
08/20/2008EP1957490A1 Novel indolizine derivatives, method for preparing same and therapeutic compositions comprising same
08/20/2008EP1957489A2 Bis-heterocyclic imidazolyl compounds
08/20/2008EP1957488A1 3-amino-2-arylpropyl azaindoles and uses thereof
08/20/2008EP1957487A1 Novel pyridopyrazines and their use as modulators of kinases
08/20/2008EP1957486A1 Compositions and methods for modulating gated ion channels
08/20/2008EP1957485A2 Substituted 4-amino-pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis
08/20/2008EP1957484A2 Glucagon receptor antagonists, preparation and therapeutic uses
08/20/2008EP1957483A1 Novel vinylogous acids derivatives
08/20/2008EP1957481A1 Pyrrolidin(thi)ones heterocyclically substituted in 3-position
08/20/2008EP1957480A1 Substituted oxindol-derivatives, medicaments containing said derivatives and use thereof
08/20/2008EP1957479A2 1,5-substituted indol-2-yl amide derivatives
08/20/2008EP1957478A2 New compounds
08/20/2008EP1957477A1 1h-benzimidazole-4-carboxamides substituted with phenyl at the 2-position are potent parp inhibitors
08/20/2008EP1957476A1 L-alanine derivatives
08/20/2008EP1957475A1 Chromenones and their use as modulators of metabotropic glutamate receptors
08/20/2008EP1957474A1 Synthesis of inhibitors of ftsz
08/20/2008EP1957471A1 7-(2-amino-1-hydroxy-ethyl)-4-hydroxybenzothiazol-2(3h)-one-derivatives as 2 adrenoceptor agonists
08/20/2008EP1957469A1 Antiproliferative pyrimidyl, fused pyrimidyl and pyrimidyl hydrazones
08/20/2008EP1957468A2 Polyalkylene glycol derivatives of 4 - (phenylamino)quinazolines useful as irreversible inhibitors of epidermal growth factor receptor tyrosine kinase
08/20/2008EP1957467A2 Spirocyclic derivatives
08/20/2008EP1957466A1 4-aminopyrimidine-5-thione-derivatives for the treatment of cancer
08/20/2008EP1957464A1 INDAZOLE DERIVATIVES THAT INHIBIT TRPVl RECEPTOR
08/20/2008EP1957462A2 Novel 2-amino-heterocycles udeful in the treatment of abeta-related pathologies
08/20/2008EP1957461A1 Bisamide inhibitors of hedgehog signaling
08/20/2008EP1957460A1 Bicyclic compounds with kinase inhibitory activity
08/20/2008EP1957452A1 Novel forms of [r-(r*,r*)]-2-(4-fluorophenyl)-b,b-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1h-pyrrole-1-hept anoic acid magnesium
08/20/2008EP1957451A1 Soft anticholinergic zwitterions
08/20/2008EP1957450A1 Serotonin transporter (sert) inhibitors
08/20/2008EP1957449A1 Compounds for the treatment of inflammatory disorders and microbial diseases
08/20/2008EP1957448A1 Substituted azacycloalkanes useful for treating cns conditions
08/20/2008EP1957444A2 2,3,4,5-tetrahydroxy-6-sulfooxyhexanoic acid and its metal salts for medical use
08/20/2008EP1957168A2 Glucan compositions
08/20/2008EP1957167A1 Composition in the form of a spray containing a vitamin d derivative and an oil phase
08/20/2008EP1957121A2 Acute treatment of social phobia
08/20/2008EP1957098A1 Management of non septic patients suffering from partial thickness burns during the first 48 postburn hours by administration of activated protein c
08/20/2008EP1957089A2 Carbodiimide crosslinking of functionalized polethylene glycols
08/20/2008EP1957088A1 Viscosupplementation with algal polysaccharides in the treatment of arthritis
08/20/2008EP1957087A1 Compositions for external application, containing adenosyl cobalamin for improvement of skin diseases
08/20/2008EP1957086A2 Nicotinoyl riboside compositions and methods of use
08/20/2008EP1957085A2 Macrolides as anti-inflammatory agents
08/20/2008EP1957084A1 Composition containing oligosaccharides for the treatment / prevention of infections
08/20/2008EP1957083A1 Beta glycolipids as immuno-modulators
08/20/2008EP1957082A1 Use of high-dose oxazaphosphorine drugs for treating immune disorders
08/20/2008EP1957081A1 Oral pharmaceutical dosage form comprising as active ingredients a proton pump inhibitor together with acetyl salicyclic acid
08/20/2008EP1957080A2 Topical glucocorticosteroid formulations
08/20/2008EP1957079A1 Use of a combination of ethynylestradiol and chlormadinone acetate for the treatment of mood changes
08/20/2008EP1957078A2 Pyrrolotriazine derivatives useful for treating cancer through inhibition of aurora kinase
08/20/2008EP1957077A2 Substituted 4-amino-pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis
08/20/2008EP1957076A2 Thiazole derivatives as cxcr3 receptor modulators
08/20/2008EP1957075A2 Novel m3 muscarinic acetylcholine receptor antagonists
08/20/2008EP1957074A2 Formulations of quinolinones
08/20/2008EP1957073A2 Medicinal drug
08/20/2008EP1957072A1 Treatment of asthma and copd using triple-combination therapy
08/20/2008EP1957071A1 Aerosol formulation for inhalation containing an anticholinergic agent
08/20/2008EP1957070A1 Aerosol formulation for inhalation containing an anticholinergic agent
08/20/2008EP1957069A2 Treatment of cancers with acquired resistance to kit inhibitors
08/20/2008EP1957068A2 Glucagon receptor antagonists, preparation and therapeutic uses
08/20/2008EP1957067A1 Indolone compounds useful to treat cognitive impairment
08/20/2008EP1957065A1 Estrogen cancer therapy
08/20/2008EP1957064A2 Treatment of qt interval prolongation and diseases associated therewith
08/20/2008EP1957062A2 Unsaturated fatty acids as thrombin inhibitors
08/20/2008EP1957061A1 Methods for the treatment of muscle loss
08/20/2008EP1957060A2 Cancer treatment using fts and 2-deoxyglucose
08/20/2008EP1957059A1 Androgen-receptor (ar) ligands for use in the treatment and diagnosis of ar-related pathologies
08/20/2008EP1957058A1 Compounds for the treatment of inflammatory disorders and microbial diseases
08/20/2008EP1957057A1 Structural carotenoid analogs or derivatives for the modulation of systemic and/or target organ redox status
08/20/2008EP1957056A2 Histone deacetylase (hdac) inhibitors (pxdlol) for the treatment of cancer alone or in combination with chemotherapeutic agent
08/20/2008EP1957055A2 Patch
08/20/2008EP1957053A2 Biocompatible latent emulsifiers
08/20/2008EP1957052A2 A gastric retention drug delivery system
08/20/2008EP1957051A1 Intraorally rapidly disintegrating tablet
08/20/2008EP1957048A2 Solid orally administerable pharmaceutical dosage forms with rapid active principle release
08/20/2008EP1957046A1 Orally administrable extended release pellet and tablet formulations of a highly water soluble compound
08/20/2008EP1957043A2 Aerosol formulation for inhalation containing an anticholinergic agent
08/20/2008EP1957042A2 Aerosol formulation for inhalation containing an anticholinergic agent
08/20/2008EP1957040A2 Benzimidazole non-aqueous compositions
1 ... 3125 3126 3127 3128 3129 3130 3131 3132 3133 3134 3135 3136 3137 3138 3139 3140 3141 3142 3143 3144 3145 ... 7860